Inventor

YAO WEI

CN104 patents

⚠️ This page may combine multiple inventors who share the name “YAO WEI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

YAO WEI

INTRA CELLULAR THERAPIES INC

Preparation of certain [((6BR,10AS)-2,3,6B,7,8,9,10, 10A-octahydro-1H-pyrido[3′,4′:4,5]pyrrolo [1,2,3-de]quinoxalines and pharmaceutically acceptable salts thereof

Preparation of 4-((6BR,10AS)-3-methyl-2,3,6B,9,10, 10A-hexahydro-1H-pyrido[3′,4′:4,5]pyrrolo [1,2,3-de]quinoxalin-8-(7H)-yl)-1-(4-fluorophenyl)-1-butanone or a pharmaceutically acceptable salt thereof

Transmucosal and subcutaneous compositions

Organic compounds

Pharmaceutical compositions comprising ((6bR,10aS)-1-(4-fluorophenyl)-4-(3-methyl-2,3,6b,9,10,10a-hexahydro-1H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl)butan-1-one or pharmaceutically acceptable salts thereof

Organic compounds

Preparation of certain substituted [((6bR,10aS)-2,3,6b,7,8,9,10,10a-octahydro-1H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalines and pharmaceutically acceptable salts thereof

Transmucosal methods for treating psychiatric and neurological conditions

Organic compounds

Organic compounds

Organic compounds

Preparation of certain substituted 1H-pyrido[3&#39;,4&#39;:4,5]pyrrolo[1,2,3-de]quinoxalines and pharmaceutically acceptable salts thereof

Transmucosal methods for treating psychiatric and neurological conditions

Organic compounds

Preparation of certain substituted 1-(4-fluorophenyl)-4-(2,3,6b,9,10,10a-hexahydro-1H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-YL)butan-1-ones and pharmaceutically acceptable salts thereof

Organic compounds

Organic compounds

Transmucosal methods for treating psychiatric and neurological conditions

Transmucosal methods for treating psychiatric and neurological conditions

APPLE INC

Dynamic backlight control system

Reducing errors in data by dynamically calibrating trigger point thresholds

Conforming, electro-magnetic interference reducing cover for circuit components

Compact display flex and driver sub-assemblies

SEAGATE TECHNOLOGY LLC

Glide heads and methods for making glide heads

Recognizing and compensating for disk shift in computer disk drives

Glide test head assembly with high take-off resolution

TOMESCH JOHN CHARLES

Substituted 2,3,4,4A,5,9B-hexahydro-1H-pyrido[4,3-B]indole derivatives synthesis and uses thereof

Substituted heterocycle gamma-carbolines synthesis

YAO WEI

Backlight control of electronic device

Method for moving targets tracking and number counting

HON HAI PREC IND CO LTD

Cable connector assembly with improved wire organizer

Cable connector assembly with improved grounding member

UNIV CALIFORNIA

LLP2A-bisphosphonate conjugates for osteoporosis treatment

LLP2A-bisphosphonate conjugates for osteoporosis treatment

HENKEL AG & CO KGAA

EMI shielding composition and process for applying it

Single crystal alumina filled die attach paste

ARTHREX INC

Surgical imaging system and method for processing surgical images

SIPIX IMAGING INC

Electrophoretic display driving scheme

CHUNG JERRY

Electrophoretic display driving approaches

COULTER INT CORP

Method of analyzing nucleated red blood cells in a blood sample

KIM MOON

Shielding structures for wireless electronic devices with displays

LAM KIT S

LLP2A-bisphosphonate conjugates for osteoporosis treatment

GETTEMY SHAWN

Systems and methods for testing a peripheral interfacing with a processor according to a high-speed serial interface protocol

VIERI CARLIN

Display having a transistor-degradation circuit

TYCO ELECTRONICS SHANGHAI CO LTD

Connector

YANG HONGWEN

Stacked electrical connector

LV BIAOBING

Plug connector and connector assembly

WURZEL JOSH

Method of shielding an electronic component from electromagnetic interference (EMI)

SHANGHAI AWINIC TECHNOLOGY CO LTD

Detection circuit and electronic device using the same

AGENCY SCIENCE TECH & RES

Method and system for processing an input image based on a guidance image and weights determined thereform

Preparation of certain substituted 1H-pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxalines and pharmaceutically acceptable salts thereof